The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBigblu Broadb. Regulatory News (BBB)

Share Price Information for Bigblu Broadb. (BBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.50
Bid: 41.00
Ask: 44.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.317%)
Open: 42.50
High: 42.50
Low: 42.50
Prev. Close: 42.50
BBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Reorganisation

15 Dec 2005 14:30

Berkeley Berry Birch PLC15 December 2005 Proposed Capital Reorganisation, amendment of Articles of Association and Notice of Extraordinary General Meeting Berkeley Berry Birch plc ("BBB" or the "Company") is today sending a circular toshareholders of the Company setting out full details of its proposed capitalreorganisation. The Company announced on 1 December 2005 that it was requesting a suspension oftrading in its ordinary shares. In that announcement BBB stated that progresswas being made in addressing the Company's regulatory capital shortfall andfuture working capital requirements. The Company is working on proposals torectify the regulatory capital shortfalls by means of planned disposals and anequity fundraising. These plans are being advanced but, to date, the FinancialServices Authority has not satisfied itself of the adequacy of these proposals. In order to facilitate any fundraising, the Company is undertaking areorganisation of its existing share capital. This capital reorganisation isnecessitated by the Companies Act 1985 (the "Act"), which prevents companiesfrom issuing shares at a discount to their par value. The par value of anordinary share is currently 10 pence, as compared with a market price of 5 penceper share at the close of business on 30 November 2005 (the latest practicabledate prior to the suspension of trading in the ordinary shares of the Company).Consequently, it is proposed to sub-divide each of the existing ordinary sharesof 10 pence into 1 ordinary share of 1 penny and 9 deferred shares of 1 pennyeach. Other than the change in par value the ordinary shares of 1 penny eachwill have the same rights as the existing ordinary shares, including voting,dividend and other rights. The deferred shares will effectively be worthless andcollectively have a negligible value following the capital reorganisation.All of the ordinary shares resulting from the capital reorganisation will, whenissued and fully paid, rank in full for all dividends and distributions made,paid or declared after the date of the capital reorganisation and otherwise paripassu in all respects. The ordinary shares can be held in certificated anduncertificated form. For those ordinary shares held in certificated form, newshare certificates will despatched shortly after these shares are admitted totrading. Application will be made to the UK Listing Authority and the London StockExchange for the ordinary shares of 1 penny resulting from the capitalreorganisation to be admitted to listing on the Official List and to trading onthe London Stock Exchange's main market for listed securities. It is expectedthat admission will become effective and that dealings in the ordinary shareswill commence at the same time as the suspension of trading in the Company'sordinary shares is lifted. Following the capital reorganisation the number of ordinary shares in issue willbe 91,788,604, giving the Company a market capitalisation of £4.6 million at themid-market price of 5 pence (the latest practicable date prior to the suspensionof trading in the ordinary shares of the Company). Shareholders approval for the capital reorganisation is being sought at anextraordinary general meeting ("EGM") convened for 11.00a.m. on 9 January 2006.At the EGM it is also being proposed to increase the Company's authorised sharecapital in order to enable any equity fundraising to take place. This proposedincrease will leave the Company with a balance of authorised but unissuedordinary share capital (which is not reserved for issue in respect ofoutstanding options) of 116,666,667 Ordinary Shares having a nominal value of£1,166,667 (representing 127.10 per cent. of the Company's issued share capital)which the Directors believe is an appropriate level of authorised but unissuedshare capital to cover any equity fundraising. Shareholder authority is also being sought at the EGM to permit the board toissue shares required to implement any fundraising and to provide an appropriatelevel of authorised but unissued share capital following completion of anyfundraising which the directors have authority to allot, subject always to thestatutory rights of pre-emption contained in section 89 of the Act. Thedisapplication of the statutory rights of pre-emption referred to above which isbeing proposed at the EGM is also required to implement any proposed fundraisingand to provide limited authority to allot shares for cash thereafter otherwisethan pro rata to shareholders. As the capital reorganisation will involve the creation of deferred shares theCompany will need to amend its articles of association to set out the rightsattaching to the deferred shares and this will also require shareholder approvalat the EGM. The rights attaching to the deferred shares (as reflected in the proposedamendments to the articles of association) will be as follows, namely: • no rights to participate in or receive any dividends declared made or paid bythe Company, • no right to receive notice of, attend or vote at any general or class meeting(other than a class meeting of the deferred shares) of the Company; • a limited right to a return of capital in a winding-up after the rights of theholders of the ordinary shares have been discharged in full and a sum of £1 hasbeen paid in respect of each issued ordinary share but no other right toparticipate in the assets of the Company; and • the approval of the directors of the Company shall be required for anytransfer of the deferred shares. As soon as the Company is in a position to inform shareholders fully of itsproposals to rectify its regulatory capital shortfalls a further circular willbe sent to shareholders prior to any fundraising being implemented. Furthershareholder approval will be required at that time to effect any suchfundraising. Enquiries: BBB plcJonathan Hall 02476 232010 Arden PartnersAndrew Raca, Director, Corporate Finance 0121 423 8941 End 15/12/05 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Feb 20244:22 pmRNSDirector/PDMR Shareholding
14th Feb 20247:00 amRNSDirector/PDMR Shareholding
16th Jan 20245:10 pmRNSDirector/PDMR Shareholding
9th Jan 20242:30 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSDirector/PDMR Shareholding
28th Dec 20233:00 pmRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSHalf-year Report
9th Jun 20237:00 amRNSIssue of Equity
5th Jun 20237:00 amRNSTrading Update for six month period to 31 May 2023
24th May 20231:50 pmRNSResult of AGM
2nd May 20237:00 amRNSPublication of Annual Report and AGM Notice
20th Mar 20237:00 amRNSAnnual Financial Report
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Feb 20233:42 pmRNSDirector/PDMR Shareholding
8th Feb 20239:54 amRNSDirector/PDMR Shareholding
2nd Feb 20237:00 amRNSAcquisition
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
20th Dec 202211:00 amRNSDirector/PDMR Shareholding
16th Dec 202210:00 amRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSTrading Update
5th Dec 20227:00 amRNSAcquisition
7th Sep 20227:00 amRNSIssue of Equity and Total Voting Rights
30th Aug 20227:00 amRNSInterim Results
4th Jul 20227:00 amRNSTrading Update
20th May 20227:00 amRNSResult of AGM
26th Apr 20227:00 amRNSPosting of Annual Report and Notice of AGM
1st Apr 202210:00 amRNSChange of Registered Office
21st Mar 20224:41 pmRNSSecond Price Monitoring Extn
21st Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 20227:00 amRNSFinal Results
23rd Feb 202211:05 amRNSSecond Price Monitoring Extn
23rd Feb 202211:00 amRNSPrice Monitoring Extension
23rd Dec 202112:09 pmRNSIssue of Equity and Total Voting Rights
21st Dec 202112:12 pmRNSIssue of Equity and Total Voting Rights
2nd Dec 20217:00 amRNSTrading Update
1st Nov 20217:00 amRNSDirector Dealing, Issue of Equity & TVR
26th Oct 20217:00 amRNSDirector Dealing, Issue of Equity & TVR
14th Oct 202112:36 pmRNSDirector Dealing
8th Oct 20211:30 pmRNSHolding(s) in Company
8th Oct 20211:30 pmRNSDirector/PDMR Shareholding
7th Oct 20213:45 pmRNSDirector/PDMR Shareholding
7th Oct 20213:45 pmRNSHolding(s) in Company
4th Oct 20217:00 amRNSDirector Dealing
30th Sep 20212:00 pmRNSDirector Dealing, Issue of Equity & TVR
30th Sep 20211:45 pmRNSResult of General Meeting
24th Sep 202112:02 pmRNSIssue of Equity
22nd Sep 20217:00 amRNSDirector Dealing, Issue of Equity and TVR
21st Sep 20217:00 amRNSReturn of Capital Timetable
31st Aug 20217:00 amRNSInterim Results & Proposed Return of Capital
3rd Aug 20211:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.